Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2101-2105

  Skacel, Marek ^a   Fahmy, Mona ^a   Brainard, Jennifer A ^a   Pettay, James D ^a   Biscotti, Charles V ^a   Liou, Louis S ^a   Procop, Gary W ^a   Stephen Jones, J ^a   Ulchaker, James ^a   Zippe, Craig D ^a   Tubbs, Raymond R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bladder; Carcinoma, transitional cell; Cytology; Hybridization, fluorescence in situ; Urine

Indexed keywords

ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER STAGING; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MOLECULAR PROBE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

EID: 0038287495     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000066842.45464.cc     Document Type: Article

References (19)

1. Ro, J. Y. Staerkel, G. A. and Ayala, A. G.: Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am, 19: 435, 1992
2. Bastacky, S., Ibrahim, S., Wilczynski, S. P. and Murphy, W. M.: The accuracy of urine cytology in daily practice. Cancer, 87: 118, 1999
3. Renshaw, A. A.: Subclassifying atypical urinary cytology specimens. Cancer, 90: 222, 2000
4. Halling, K. C., King, W., Sokolova, I. A., Meyer, R. G., Burkhardt, H. M., Halling, A. C. et al: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelium carcinoma. J Urol, 164: 1768, 2000
5. Bubendorf, L., Grilli, B., Sauter, G., Mihatsch, M. J., Gasser, T. C. and Dalquen, P.: Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol, 116: 79, 2001
6. Halling, K. C., King, W., Sokolova, I. A., Karnes, R. J., Meyer, R. G., Powell, E. L. et al: A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol, 167: 2001, 2002
7. Junker, K., Hartmann, A., Tanke, H. J., Morrison, L., Obermann, E., Wiegant, J. et al: Evaluation of a multi-color fluorescence in situ hybridization assay for the detection of bladder cancer - results from three European laboratories. J Urol, suppl., 167: 164, abstract 657, 2002
8. Skacel, M., Pettay, J. D., Tsiftsakis, E. K., Procop, G. W., Biscotti, C. V. and Tubbs, R. R.: Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thinlayer, liquid-based cytology slides. Anal Quant Cytol Histol, 23: 381, 2001
9. Operator's Manual. ThinPrep processor. Boxborough, Massachusetts: CYTYC Corp., 1992
10. Takahashi, T., Lohse, C., Pankratz, V. S., Karnes, R. J., Sarosdy, M. F., Jenkins, R. B. et al: Predicting urothelial carcinoma recurrence with fluorescence in situ hybridization analysis of urine. J Urol, suppl., 167: 162, abstract 651, 2002
11. King, W., Proffitt, J., Morrison, L., Piper, J., Lane, D. and Seelig, S.: The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management. Mol Diagn, 5: 309, 2000
12. Sidransky, D. and Messing, E.: Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am, 19: 629, 1992
13. Tsai, Y. C., Nichols, P. W., Hiti, A. L., Williams, Z., Skinner, D. G. and Jones, P. A.: Allelic losses of chromosomes 9, 11 and 17 in human bladder cancer. Cancer Res, 50: 44, 1990
14. Hopman, A. H., Mopesker, O., Smeets, A. W., Pauwels, R. P., Vooijs, G. P. and Ramaekers, F. C.: Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res, 51: 644, 1991
15. Meloni, A. M., Peier, A. M., Kingsley, K. L. and Sandberg, A. A.: FISH studies of urinary cells of patients with bladder cancer. Urol Oncol, 1: 234, 1995
16. Meloni, A. M., Peier, A. M., Haddad, F. S., Powell, I. J., Block, A. W., Huben, R. P. et al: A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Genet Cytogenet, 71: 105, 1993
17. Sokolova, I. A., Halling, K. C., Jenkins, R. B., Burkhardt, H. M., Meyer, R. G., Seelig, S. A. et al: The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn, 2: 116, 2000
18. Drew, P. A., Furman, J., Civantos, F. and Murphy, W. M.: The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol, 9: 989, 1996
19. Sarosdy, M. F., Schellhammer, P., Bokinsky, G., Kahn, P., Chao, R., Yore, L. et al: Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol, 168: 1950, 2002